In recognition of Sickle Cell Disease Association of America (SCDAA), Inc.’s 50th anniversary, we have launched this limited, three-part speaker series, Masterclass on Sickle Cell Disease. Leading experts in sickle cell disease focus on novel concepts surrounding disease-modifying and curative therapies and their impact on those living with sickle cell disease. The goal is to approach key sickle cell topics with a fresh, innovative perspective through discussions that have not yet been had. Learn more about the series here.
The Perfect Red Blood Cell: An SC Dream Redefined
LIVE at the SCDAA Annual National Convention
Gene Therapy: A Journey Forward
Our panelists, including SCDAA Chief Medical Officer Lewis Hsu, M.D., and Edward Donnell Ivy, M.D., SCDAA vice chief medical officer, explore the role of gene therapy in our journey forward. The discussion is moderated by Andrew Campbell, M.D., director of the Children’s National Comprehensive Sickle Cell Disease Program.
All Things Considered – SCD Treatment: A Personal Choice
Co-hosts Teonna Woolford and Dr. Wanda Whitten-Shurney will discuss the many considerations that go into making a decision to choose disease modifying treatments or curative therapies. Panelists will include speakers who share their lived SCD experiences, the choices they made and why.